Welcome to our dedicated page for Vicor SEC filings (Ticker: VICR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vicor Corporation (VICR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Vicor is a NASDAQ-listed issuer whose common stock is registered under Section 12(b) of the Exchange Act, and its filings give structured insight into the business of designing, developing, manufacturing and marketing modular power components and complete power systems based on patented technologies.
Investors can use this page to review Vicor’s current reports on Form 8-K, which include items such as quarterly earnings announcements and the results of the annual meeting of stockholders. For example, recent 8-K filings reference financial results for periods ended March 31, June 30 and September 30, 2025, and a filing describing matters submitted to a vote of security holders at the 2025 Annual Meeting. These documents also confirm that Vicor’s common stock trades on The NASDAQ Stock Market LLC under the symbol VICR.
In addition to 8-Ks, Vicor’s broader SEC reporting framework includes annual reports on Form 10-K and quarterly reports on Form 10-Q, which the company references in its press releases. These filings contain sections such as “Business,” “Risk Factors,” “Legal Proceedings” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” as well as audited and unaudited financial statements. Together, they outline Vicor’s operations in modular power components and systems, its intellectual property position, and financial details such as product and royalty revenues, margins and cash flows.
The filings page also surfaces proxy and governance-related information, such as disclosures about the annual meeting and the election of directors, as seen in the 8-K describing the 2025 Annual Meeting vote. For users interested in executive and board matters, capital structure, or voting results, these documents provide the official record.
Stock Titan enhances access to these filings with AI-powered summaries that explain key points from lengthy documents, helping users quickly understand what Vicor reports about its financial condition, results of operations, risk factors and corporate actions. Real-time updates from the SEC’s EDGAR system ensure that new VICR filings, including 10-Ks, 10-Qs, 8-Ks and related exhibits, appear promptly, while AI-generated highlights make it easier to interpret complex regulatory language without replacing the need to consult the full filings.
Vicor Corp (VICR) – Form 4 insider filing dated 06/23/2025
Director John Zheng Shen received a grant of 4,539 non-qualified stock options on 06/20/2025 under the company’s Amended & Restated 2000 Stock Option and Incentive Plan. The options carry an exercise price of $44.07 per share and expire on 06/20/2035. No shares were bought or sold in the open market; the transaction strictly reflects a compensation-related award. Following the grant, Shen beneficially owns 4,539 derivative securities linked to common stock, held directly.
The filing is routine and does not disclose any immediate cash transactions, changes in ownership percentage, or broader strategic implications for Vicor’s capital structure.
Vicor Corp (VICR) – Form 4 insider filing dated 06/23/2025 discloses that Claudio Tuozzolo, a Corporate Vice President and Director, received a grant of 4,539 non-qualified stock options on 06/20/2025 under the company’s Amended & Restated 2000 Stock Option and Incentive Plan. The options have an exercise price of $44.07, a 10-year term expiring 06/20/2035, and will vest over five years (standard 20 % per-year schedule implied by plan language). No cash consideration was paid for the grant (price $0).
No shares of common stock were acquired or disposed of in Table I; Tuozzolo’s direct beneficial ownership remains 33,622 shares following the transaction. After the option grant, he also directly holds 4,539 derivative securities. The filing includes the customary signature by attorney-in-fact on 06/23/2025 and contains no indications of a Rule 10b5-1 trading plan or any sales activity.
From an investor perspective, the filing represents routine equity-based compensation aimed at aligning executive incentives with shareholder interests. It does not alter Vicor’s capital structure, cash flow, or immediate financial outlook. The relatively modest size of the option grant (≈0.01 % of the 43 million shares outstanding) suggests minimal dilution risk and limited market impact.
Vicor Corporation (VICR) – Form 4 insider transaction summary
On 06/20/2025, director Andrew D’Amico received a non-qualified stock option for 4,539 common shares of Vicor. The option’s exercise price is $44.07—generally the market price at the grant date—and it will expire on 06/20/2035. According to the footnote, the grant was made under the company’s Amended and Restated 2000 Stock Option and Incentive Plan and will vest ratably over five years. No shares were purchased or sold outright; the filing only records the derivative security grant. Following the transaction, D’Amico beneficially owns 4,539 derivative securities (options) and no change to any direct common-stock position is disclosed.
This type of grant is a routine component of director compensation. It modestly aligns the director’s interests with shareholders by linking potential value to future share-price performance, but the size of the grant—4,539 shares, roughly US$0.2 million based on the strike price—is small relative to Vicor’s market capitalization and average daily trading volume. There are no cash proceeds to Vicor and no immediate dilution because the options are unexercised. Investors should consider it an ordinary governance event rather than a signal of near-term fundamental change.
Vicor Corp (VICR) – Form 4 Insider Filing
Director Estia J. Eichten reported the grant of 4,539 non-qualified stock options on 20 June 2025 at an exercise price of $44.07 per share, expiring 20 June 2035. The award was issued under the company’s Amended and Restated 2000 Stock Option and Incentive Plan and will vest over five years, reinforcing long-term alignment with shareholders. No open-market purchases or sales of common stock were disclosed in Table I; the director continues to hold 230,267 shares of Vicor common stock directly after the reported transaction.
The filing indicates routine equity-based compensation for a board member and does not materially alter the company’s share count or insider ownership structure. Because the transaction is an acquisition of derivative securities rather than a disposition, it does not signal near-term liquidity by the insider. Overall, the Form 4 suggests continued commitment by the director but carries limited financial impact for investors given the modest size of the award relative to Vicor’s outstanding shares and daily trading volume.
On June 20, 2025, Vicor Corp (VICR) filed a Form 4 detailing an equity award to its Chief Financial Officer, Treasurer, Secretary and Director, James F. Schmidt.
The filing shows a grant of 4,539 non-qualified stock options with an exercise price of $44.07 per share under the company’s Amended and Restated 2000 Stock Option and Incentive Plan. The options vest over five years and expire on June 20, 2035. After the grant, Mr. Schmidt directly holds 4,539 options and 875 shares of common stock.
No purchases or sales of common shares were reported. Given the award’s small size relative to Vicor’s total shares outstanding, the disclosure is routine and implies minimal dilution.
On 06/23/2025, Vicor Corp. (VICR) filed a Form 4 disclosing that director Zmira Lavie received an equity incentive grant on 06/20/2025. The award consists of 4,539 non-qualified stock options with an exercise price of $44.07 per share, issued under the company’s Amended and Restated 2000 Stock Option and Incentive Plan. The options vest over five years and carry an expiration date of 06/20/2035. Following the grant, Lavie beneficially owns 4,539 derivative securities and reported no open-market purchases or sales of common stock. As this is a routine director compensation grant representing an immaterial fraction of Vicor’s outstanding shares, the filing is considered neutral from a near-term valuation perspective.